- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1472-6963
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The economic impact of compassionate use of medicines ; volume:21 ; number:1 ; day:4 ; month:12 ; year:2021 ; pages:1-13 ; date:12.2021
BMC health services research ; 21, Heft 1 (4.12.2021), 1-13, 12.2021
- Creator
-
Jommi, Claudio
Pantellini, Federico
Stagi, Lisa
Verykiou, Maria
Cavazza, Marianna
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12913-021-07255-w
- URN
-
urn:nbn:de:101:1-2022020720175223219114
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:20 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Jommi, Claudio
- Pantellini, Federico
- Stagi, Lisa
- Verykiou, Maria
- Cavazza, Marianna
- SpringerLink (Online service)
Other Objects (12)
Ethics review in compassionate use
Compassionate use of experimental therapies: who should decide?
Letermovir for the compassionate therapeutic use of cytomegalovirus infection
Compassionate use programs in Italy: ethical guidelines
Journal of Compassionate Health Care
Compassionate use of others’ immunity — understanding gut microbiome in Covid-19
Compassionate use of roxadustat for treatment of refractory renal anemia in an infant
Structural violence and the need for compassionate use of methadone in Mexico
Compassionate use programmes for rare diseases: proposals for actions
An analysis of common ethical justifications for compassionate use programs for experimental drugs
Characterizing expanded access and compassionate use programs for experimental drugs
Exploring the Use of Traditional Medicines, Natural Health Products and Conventional Medicines: Development and Testing of the New Zealand ‘All-Medicines’ Questionnaire
Ethics review in compassionate use
Compassionate use of experimental therapies: who should decide?
Letermovir for the compassionate therapeutic use of cytomegalovirus infection
Compassionate use programs in Italy: ethical guidelines
Journal of Compassionate Health Care
Compassionate use of others’ immunity — understanding gut microbiome in Covid-19
Compassionate use of roxadustat for treatment of refractory renal anemia in an infant
Structural violence and the need for compassionate use of methadone in Mexico
Compassionate use programmes for rare diseases: proposals for actions
An analysis of common ethical justifications for compassionate use programs for experimental drugs
Characterizing expanded access and compassionate use programs for experimental drugs
Exploring the Use of Traditional Medicines, Natural Health Products and Conventional Medicines: Development and Testing of the New Zealand ‘All-Medicines’ Questionnaire
Ethics review in compassionate use
Compassionate use of experimental therapies: who should decide?
Letermovir for the compassionate therapeutic use of cytomegalovirus infection
Compassionate use programs in Italy: ethical guidelines
Journal of Compassionate Health Care
Compassionate use of others’ immunity — understanding gut microbiome in Covid-19
Compassionate use of roxadustat for treatment of refractory renal anemia in an infant
Structural violence and the need for compassionate use of methadone in Mexico
Compassionate use programmes for rare diseases: proposals for actions
An analysis of common ethical justifications for compassionate use programs for experimental drugs
Characterizing expanded access and compassionate use programs for experimental drugs